Login / Signup

Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting.

Lyndon Marc EvansRoopa MehtaJens GundgaardBarrie Chubb
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Novo Nordisk, Søborg, Denmark.
Keyphrases
  • glycemic control
  • type diabetes
  • weight loss
  • insulin resistance
  • cross sectional
  • cardiovascular disease
  • adipose tissue
  • metabolic syndrome
  • cardiovascular risk factors